Skip to Content

Join the 'Thrombocytopenia' group to help and get support from people like you.

Thrombocytopenia News

FDA Approves New Indication for Promacta (eltrombopag)

Posted 20 Nov 2012 by

LONDON, Nov. 19, 2012 – GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Promacta for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.  Promacta is the first supportive care treatment available to patients who are ineligible or poor ...

Ask a Question

Further Information

Related Condition Support Groups

Idiopathic (Immune) Thrombocytopenic Purpura, Thrombocytopenia Drug Induced, Thrombocytopenia Autoimmune, Thrombocytopenia Idiopathic, Bleeding Disorder

Related Drug Support Groups

prednisone, dexamethasone, Decadron, Deltasone, Promacta, eltrombopag, Liquid Pred, Sterapred, Sterapred DS, view more... Dexone, Adrenocot, Adrenocot LA, Orasone, Prednicen-M, Prednicot, Baycadron, Dexamethasone Intensol, Dalalone, Dalalone DP, Dalalone LA, Decaject, Decaject LA, Meticorten, Dexacorten, Dexpak Taperpak, De-Sone LA, Cerezyme, Hexadrol, Decadron-LA, Solurex LA, Dexacen-4, Solurex, Dexacort-LA, Medidex LA, Dexasone, Dexasone LA, Dexone LA, Primethasone, imiglucerase, Medidex, Zema Pak